STAQ Pharma Introduces Two New Methadone

Products to its Portfolio!

Methadone HCl PF 10mg/mL in NaCl and Methadone HCl PF 1mg/mL in NaCl, both now available for pre-order. These new formulations complement our current inventory, including the Methadone HCl PF 5mg/5mL in NaCl, which is available for immediate shipment. See below for more details!

Methadone HCl PF 10mg/1mL in NaCl 

• 1 mL in a 3 mL Syringe
• Launch Date: March 22nd
• Beyond Use Date (BUD): For initial release, the BUD will be 60 days. We plan to have a BUD of 90 Days week of April 22nd.

Methadone HCl PF 1mg/1mL in NaCl

• 1 mL in a 3 mL Syringe
• Launch Date: Week of April 22nd.
• Beyond Use Date (BUD): 90 Days

Current Available Product

Methadone HCl PF 5mg/5mL in NaCl 

• 5 mL in a 5 mL Syringe
• Beyond Use Date (BUD): 180 Days
• In stock and available for shipment today!

For more information about ordering, reach out to your dedicated account representative, or email us at staqpharma@staqpharma.com. 

STAQ Pharma is an FDA-registered 503B Outsourcing Supplier with over 10 hospital partners. STAQ has two operating facilities: Denver, CO and Columbus, OH, both designed to meet the highest safety and regulatory requirements in compounded medications. The trust our customers have in us makes the quality of the products we manufacture our top priority. We have an extensive product portfolio that is expanding daily to offer innovative solutions.

Stay connected with us on LinkedIn!

Follow RXinsider on Social Media